121 related articles for article (PubMed ID: 11770838)
1. Effect of colestimide on intestinal absorption of ursodeoxycholic acid in men.
Takikawa H; Ogasawara T; Sato A; Ohashi M; Hasegawa Y; Hojo M
Int J Clin Pharmacol Ther; 2001 Dec; 39(12):558-60. PubMed ID: 11770838
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ileal bile acid absorption by colestimide.
Takeuchi A; Sano N; Takikawa H
J Gastroenterol Hepatol; 2003 May; 18(5):548-53. PubMed ID: 12702047
[TBL] [Abstract][Full Text] [Related]
3. Effect of colestimide on absorption of unconjugated bile acids in the rat jejunum.
Onishi T; Sano N; Takikawa H
J Gastroenterol Hepatol; 2002 Jun; 17(6):697-701. PubMed ID: 12100616
[TBL] [Abstract][Full Text] [Related]
4. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
Matsuzaki Y
J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
[No Abstract] [Full Text] [Related]
5. Studies on adsorption characteristics of bile acids and methotrexate to a new type of anion-exchange resin, colestimide.
Honda Y; Nakano M
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):978-81. PubMed ID: 10923826
[TBL] [Abstract][Full Text] [Related]
6. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
7. Influence of cholestasis on absorption of ursodeoxycholic acid.
Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
Rust C; Sauter GH; Oswald M; Büttner J; Kullak-Ublick GA; Paumgartner G; Beuers U
Eur J Clin Invest; 2000 Feb; 30(2):135-9. PubMed ID: 10651838
[TBL] [Abstract][Full Text] [Related]
9. No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.
Xiang X; Vakkilainen J; Backman JT; Neuvonen PJ; Niemi M
Eur J Clin Pharmacol; 2011 Nov; 67(11):1159-67. PubMed ID: 21655991
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).
Kawashiri MA; Higashikata T; Nohara A; Kobayashi J; Inazu A; Koizumi J; Mabuchi H
Circ J; 2005 May; 69(5):515-20. PubMed ID: 15849435
[TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.
Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
Wunsch E; Trottier J; Milkiewicz M; Raszeja-Wyszomirska J; Hirschfield GM; Barbier O; Milkiewicz P
Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
[TBL] [Abstract][Full Text] [Related]
13. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
14. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
[TBL] [Abstract][Full Text] [Related]
15. Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet.
Sakamoto S; Takeshita S; Sassa S; Suzuki S; Ishikawa Y; Kudo H
In Vivo; 2005; 19(6):1029-33. PubMed ID: 16277017
[TBL] [Abstract][Full Text] [Related]
16. Rapid improvement of icterus and pruritus by the oral administration of colestimide in two cases of drug-induced hepatitis.
Tani M; Hayashi Y; Okamoto S; Yokohama S; Inaba M; Kubota H; Nakamura K
Intern Med; 2001 Nov; 40(11):1098-103. PubMed ID: 11757763
[TBL] [Abstract][Full Text] [Related]
17. Lack of relationship between blood glucose-lowering activity of colestimide and serum cholecystokinin (CCK) concentrations in patients with type 2 diabetes.
Suzuki T; Oba K; Norose J; Yoshimatsu H; Sekimizu K; Futami-Suda S; Ouchi M; Suzuki K; Kigawa Y; Nakano H
J Nippon Med Sch; 2008 Apr; 75(2):111-5. PubMed ID: 18475032
[TBL] [Abstract][Full Text] [Related]
18. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population.
Lee S; Yoon S; Chung H; Ji SC; Yoon SH; Yu KS; Cho JY; Chung JY
J Clin Pharmacol; 2019 Aug; 59(8):1085-1092. PubMed ID: 30882914
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.
Stiehl A
Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
